Research focusing on the pathway of IL-6, involving the action of microRNAs and regulation of the expression of BMPR2 thus is ongoing to extend these findings to other forms of pulmonary hypertension or the use of these factors as surrogate markers for the disease. Here, IL6 is linked to pulmonary hypertension.